Literature DB >> 26499886

Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.

Wei-Lu Wu1, Wei-Ya Wang1, Wen-Qing Yao1, Gan-Di Li1.   

Abstract

miR-16 is known to be abnormally expressed in hepatocellular carcinoma (HCC) cells, and the overexpression of miR-16 inhibits the proliferation, invasion and metastasis of various cancer cells. MicroRNAs (miRNAs or miRs) are closely related to the proliferation, invasion and metastasis of HCC. The present study aimed to explore the effects of miR-16 on the proliferation, invasion and metastasis of HCC cells, and to elucidate the mechanisms involved. A cell line with moderate levels of miR‑16 expression was selected from the SMMC-7721, HepG2, SK-Hep-1 and Huh‑7 HCC cells and validated by reverse transcription-PCR (RT-PCR). The effects of miR‑16 on HCC cell viability were determined by MTT assay; cell migration and invasion were determined by Transwell cell invasion assay, and apoptosis was determined by flow cytometery (FCM). Western blot analysis was used to measure the expression levels of the apoptosis-related proteins, Bax, Bcl-2, matrix metalloproteinase (MMP)-2, MMP-9, as well as to examine epithelial-mesenchymal transition (EMT), and E-cadherin, vimentin, and phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway-related protein expression. The mRNA expression levels of miR‑16 were highest in the SMMC-7721 cells and lowest in the SK-Hep‑1 and Huh‑7 cells; moderate levels were observed in the HepG2 cells. The HepG2 cell line was selected as the cell line for use in the follow-up experiments, where we measured cell viability, and the expression of PI3k/Akt, Bax, Bcl-2, MMP-2 and MMP-9, and E-cadherin and vimentin. miR‑16 overexpression significantly inhibited the proliferation, invasion and metastasis of the HepG2 cells, as shown by western blot analysis. This was achieved through the upregulation of Bax expression, the downregulation of Bcl-2 expression and the decrease in the expression of MMP-2 and MMP-9. In addition the expression of E-cadherin increased and vimentin expression decreased. miR‑16 overexpression inhibited PI3K expression and Akt phosphorylation. The results of this study suggest that the overexpression of miR‑16 inhibits the proliferation, invasion and metastasis of HepG2 HCC cells, and that these effects are associated with the PI3K/Akt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26499886     DOI: 10.3892/ijmm.2015.2379

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  21 in total

1.  Acoustically Driven Microbubbles Enable Targeted Delivery of microRNA-Loaded Nanoparticles to Spontaneous Hepatocellular Neoplasia in Canines.

Authors:  Sukumar Uday Kumar; Arsenii V Telichko; Huaijun Wang; Dongwoon Hyun; Eric G Johnson; Michael S Kent; Robert B Rebhun; Jeremy J Dahl; William T N Culp; Ramasamy Paulmurugan
Journal:  Adv Ther (Weinh)       Date:  2020-11-12

2.  * Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia.

Authors:  Anthony Monteforte; Brian Lam; Michael B Sherman; Kayla Henderson; Andrew D Sligar; Adrianne Spencer; Brian Tang; Andrew K Dunn; Aaron B Baker
Journal:  Tissue Eng Part A       Date:  2017-11       Impact factor: 3.845

Review 3.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

4.  Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.

Authors:  D D H Tran; C Kessler; S E Niehus; M Mahnkopf; A Koch; T Tamura
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

5.  MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.

Authors:  Zhenghai Shen; Xing Wang; Xiaotian Yu; Yun Zhang; Lei Qin
Journal:  Oncotarget       Date:  2017-08-07

6.  MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study.

Authors:  Paola Mozzoni; Luca Ampollini; Matteo Goldoni; Rossella Alinovi; Marcello Tiseo; Letizia Gnetti; Paolo Carbognani; Michele Rusca; Antonio Mutti; Antonio Percesepe; Massimo Corradi
Journal:  Dis Markers       Date:  2017-07-03       Impact factor: 3.434

Review 7.  Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer.

Authors:  Liviuta Budisan; Diana Gulei; Oana Mihaela Zanoaga; Alexandra Iulia Irimie; Chira Sergiu; Cornelia Braicu; Claudia Diana Gherman; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

8.  Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients.

Authors:  Thorben Fründt; Linda Krause; Elaine Hussey; Bettina Steinbach; Daniel Köhler; Johann von Felden; Kornelius Schulze; Ansgar W Lohse; Henning Wege; Heidi Schwarzenbach
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

9.  Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma.

Authors:  Shijie Qin; Jieyun Xu; Yunmeng Yi; Sizhu Jiang; Ping Jin; Xinyi Xia; Fei Ma
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

10.  miR‑15a represses cancer cell migration and invasion under conditions of hypoxia by targeting and downregulating Bcl‑2 expression in human osteosarcoma cells.

Authors:  Jiali Leng; Qingxu Song; Yuguang Zhao; Zhenyu Wang
Journal:  Int J Oncol       Date:  2018-02-23       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.